【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1 Soliris
04.2 Nplate
04.3 Revlimid
04.4 Vidaza
04.5 Promacta
04.6 Jakafi
04.7 Rituxan
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Diseases Overview
07.1 ITP
07.1.1 Understanding the Disease
07.1.2 Epidemiology
07.1.3 Etiology
07.1.4 Pathophysiology
07.1.5 Management of Disease
07.2 MDS
07.2.1 Understanding the Disease
07.2.2 Epidemiology
07.2.3 Etiology
07.2.4 Pathophysiology
07.2.5 Management of Disease
07.3 MF
07.3.1 Understanding the Disease
07.3.2 Epidemiology
07.3.3 Etiology
07.3.4 Pathophysiology
07.3.5 Management of Disease
07.4 PNH
07.4.1 Understanding the Disease
07.4.2 Epidemiology
07.4.3 Etiology
07.4.4 Pathophysiology
07.4.5 Management of Disease
07.5 PV
07.5.1 Understanding the Disease
07.5.2 Epidemiology
07.5.3 Etiology
07.5.4 Pathophysiology
07.5.5 Management of Disease
07.6 Pipeline Analysis
07.7 Emerging Treatment Options
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Indication Type
09.1.1 Market Size and Forecast for ITP
09.1.2 Market Size and Forecast for MDS
09.1.3 Market Size and Forecast for MF
09.1.4 Market Size and Forecast for PNH
09.1.5 Market Size and Forecast for PV
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Competitive Assessment of Top Drugs
18.2.2 Alexion Pharmaceuticals
18.2.3 Amgen
18.2.4 Celgene
18.2.5 F. Hoffmann-La Roche
18.2.6 GlaxoSmithKline
18.2.7 Incyte
Other Prominent Vendors
19.Key Vendor Analysis
19.1 F. Hoffmann-La Roche Ltd.
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Information
19.1.8 SWOT Analysis
19.2 Celgene
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Business Segmentation by Revenue
19.2.5 Sales by Geography
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Alexion
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Geographical Segmentation by Revenue 2013
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Amgen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Product Portfolio by Revenue 2013
19.4.5 Business Segmentation by Revenue 2012 and 2013
19.4.6 Geographical Segmentation by Revenue 2013
19.4.7 Business Strategy
19.4.8 Recent Developments
19.4.9 SWOT Analysis
19.5 Incyte
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Revenue Segmentation by 2013
19.5.4 Revenue Segmentation by 2012 and 2013
19.5.5 Geographical Segmentation
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 GlaxoSmithKline
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation
19.6.4 Business Segmentation by Revenue 2012 and 2013
19.6.5 Sales by Geography
19.6.6 Pipeline Products
19.6.7 Business Strategy
19.6.8 Key Information
19.6.9 SWOT Analysis
19.6.10 Strengths
19.6.11 Weaknesses
19.6.12 Opportunities
19.6.13 Threats
20.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of ITP
Exhibit 3: Snapshot of MDS
Exhibit 4: Snapshot of MF
Exhibit 5: Snapshot of PNH
Exhibit 6: Snapshot of PV
Exhibit 7: Global Acquired Orphan Blood Diseases Therapeutics Market 2014-2019 (US$ million)
Exhibit 8: Global Acquired Orphan Blood Diseases Therapeutics Market Segmentation by Indication Type
Exhibit 9: Global Acquired Orphan Blood Diseases Therapeutics Market Revenue Comparison by Indication, 2014 and 2019 (US$ million)
Exhibit 10: Global Acquired Orphan Blood Diseases Therapeutics Market Percent Share by Indication, 2014 and 2019
Exhibit 11: Market Size and Forecast for ITP Market 2014-2019 (US$ million)
Exhibit 12: Market Size and Forecast for MDS Market 2014-2019 (US$ million)
Exhibit 13: Market Size and Forecast for MF Market 2014-2019 (US$ million)
Exhibit 14: Market Size and Forecast for PNH Market 2014-2019 (US$ million)
Exhibit 15: Market Size and Forecast for PV Market 2014-2019 (US$ million)
Exhibit 16: Geographical Segmentation of Global Acquired Orphan Blood Diseases Therapeutics Market in 2014
Exhibit 17: Marketing Exclusivity for Orphan Drugs in Some Regions
Exhibit 18: Revenue Comparison of Top Drugs for Acquired Orphan Blood Diseases Therapeutics market in 2013 (US$ million)
Exhibit 19: Revenue Comparison and YoY Growth for Soliris from 2012-2014 (US$ million)
Exhibit 20: Global Market Forecast for Soliris from 2014-2019 (US$ million)
Exhibit 21: Revenue Comparison and YoY Growth for Nplate from 2011-2013 (US$ million)
Exhibit 22: Revenue Comparison and YoY Growth for Revlimid from 2011-2013 (US$ million)
Exhibit 23: Revenue Comparison and YoY Growth for Vidaza from 2011-2013 (US$ million)
Exhibit 24: Revenue Comparison for Rituxan from 2012-2013 (US$ million)
Exhibit 25: Revenue Comparison and YoY Growth for Promacta 2011-2014 (US$ million)
Exhibit 26: Revenue Comparison for Jakafi from 2012-2013 (US$ million)
Exhibit 27: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 28: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 29: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 30: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 31: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 32: Celgene: Sales by Geography 2013
Exhibit 33: Alexion: Geographical Segmentation by Revenue 2013
Exhibit 34: Amgen: Business Segmentation by Revenue 2013
Exhibit 35: Amgen: Product Portfolio by Revenue 2013
Exhibit 36: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 38: Incyte Corporation: Revenue Segmentation by 2013 (US$ million)
Exhibit 39: Incyte Corporation: Revenue Segmentation by 2012 and 2013 (US$ million)
Exhibit 40: Incyte Corporation: Geographical Segmentation
Exhibit 41: GlaxoSmithKline: Business Segmentation 2013
Exhibit 42: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 43: GlaxoSmithKline: Sales by Geography 2013
Exhibit 44: GlaxoSmithKline: Pipeline Products 2013
【レポート販売概要】
■ タイトル：後発性希少血液疾患治療薬の世界市場：PNH、ITP、PV、MF、MDS■ 英文：Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5409
■ 調査対象地域：グローバル
- 心房細動(Atrial Fibrillation)の治療薬パイプライン動向（2015年上半期版）Atrial Fibrillation - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- 弾道保護の世界市場2016-2020About Ballistic Protection Most of major defense spenders such as the US, UK, Germany, China, Russia, India are directing their investments on armed personnel protection. The armed personal protection refers to the ballistic protection given to the armed forces, homeland security and law enforcement officers, private security officials, and their vehicles from projectiles such as bullets, explosiv …
- 半自動/手動充填機の世界市場予測（～2020）The global semi-automatic filling equipment and manual filling equipment market is projected to reach USD 4.52 Billion by 2020, at a CAGR of 4.9% between 2015 and 2020. Technological developments, small pack size, changing consumer lifestyles, and automation in filling equipment are major factors influencing the growth of this market. Among all applications, the food & beverages segment led the gl …
- 脳脊髄液（CSF）管理機器の世界市場2017-2021ABSTRACTAbout Cerebrospinal Fluid (CSF) Management Devices CSF shunts and CSF drainage systems are used to manage or divert the CSF flow in the body away from the ventricles in a controlled manner, thereby providing an alternative pathway. Hydrocephalus is the abnormal accumulation of CSF within the brain cavities called ventricles (space near the spine). It occurs due to an imbalance in the forma …
- 繊維機械の世界市場2016-2020Technavio’s market research analyst predicts the global textile machinery market to grow at an impressive CAGR of nearly 11% by 2020. The rising demand for non-woven fabrics is the primary growth driver for this market. Non-woven fabrics are a web structure of the individual fibers that are neither woven nor knitted. High-speed and low-cost processes are employed to manufacture these fabrics. The …
- アンマネージド産業用イーサネットスイッチの世界市場2017-2021About Unmanaged Industrial Ethernet SwitchesEthernet switches used in industrial settings are different from commercial switches. Industrial Ethernet switches are designed for environments that are unfavorable to commercial switches. This can include environments with extreme temperatures, high vibrations, and several electric noises. Commercial Ethernet switches are designed to meet enterprise el …
- HPV検査の世界市場2016-2020About HPV Testing According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other type …
- 企業向けMラーニング（モバイルラーニング）の世界市場2016-2020：技術的企業向けMラーニング、非技術的企業向けMラーニングAbout Corporate M-Learning Globalization has intensified competition within and outside organizations. As a result, corporates are faced with the challenge of maintaining market leadership and customer base, as well as recruiting and retaining talent. Evolving job roles are demanding new skills, thereby increasing the reliance on external corporate training providers. Consequently, companies are b …
- 輸送機関用バッテリーの世界市場：二輪車用、自動車用、船舶用、航空用The global battery market is projected to grow at a promising CAGR of 4.15% during the forecast period, to reach USD 17.26 Billion by 2021. Increasing electrification of automobiles is one of the major factors driving this growth. The Li-Ion battery market in the automotive industry is the fastest growing battery market with its volume expected to double by 2021, owing to a global increase in elec …
- 仮想検査の世界市場2016-2020About Virtual Inspection Virtual inspection technologies represent a low-cost strategy that helps manufacturers achieve operational efficiency. Machine vision uses video cameras, analog-to-digital conversion, and digital signal processing technologies for application in surface defect detection, surface auto-vision, and AUVs. Keeping in view the evolution of technologies, we expect virtual inspect …
- 世界の兵士現代化市場：競争状況及び戦略的インサイトSummary This report shows the leading Soldier Modernization market segments in various regions across the world. Details of top companies active across the global Soldier Modernization market are provided, together with market size and forecast 2015-2025 for the main players across those areas. Key Findings The report provides a detailed analysis of the competitive landscape of the Soldier Moderni …
- スマートマテリアル(Smart Material)の世界市場：圧電材料、磁歪材料、熱電材料、形状記憶合金、レオロジー流体About Smart Materials Market Smart materials are specialty building materials whose properties tend to vary when subjected to external stimuli such as stress, temperature, moisture, pH, and magnetic field. These materials are called smart materials because of the change inherent in them, and not due to an external force. Smart materials have been on the market for many years and serve a large numb …
- Petroleos Mexicanos：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Petroleos Mexicanos Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Petroleos Mexicanos Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 世界の工業用けい砂（Industrial Silica Sand）市場動向（2012-2016）TechNavio’s analysts forecast the Global Industrial Silica Sand market to grow at a CAGR of 4.50 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of industrial silica sand for hydraulic fracturing. The Global Industrial Silica Sand market has also been witnessing the increasing focus toward R&D activities. However, increasing us …
- 艶消し剤の世界市場分析：製品別（有機（ワックス、熱可塑性樹脂）、無機（シリカ））、用途別（工業用コーティング、木材コーティング、皮革コーティング、建築用コーティング）、セグメント予測、2014 – 2025The global matting agents market is anticipated to reach USD 1.05 billion by 2025, according to a new report by Grand View Research, Inc. The growth of global paints and coatings industry coupled with its usage in industrial and architectural applications is expected to fuel the market growth over the forecast period. Matting agents alter the surface properties of an application, resulting in diff …
